- Home
- ASRV vs ITRM Comparison
ASRV vs ITRM Comparison
Compare ASRV & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASRV
- ITRM
- Stock Information
- Founded
- ASRV 1983
- ITRM 2015
- Country
- ASRV United States
- ITRM Ireland
- Employees
- ASRV N/A
- ITRM N/A
- Industry
- ASRV Major Banks
- ITRM Biotechnology: Pharmaceutical Preparations
- Sector
- ASRV Finance
- ITRM Health Care
- Exchange
- ASRV Nasdaq
- ITRM Nasdaq
- Market Cap
- ASRV 45.1M
- ITRM 49.5M
- IPO Year
- ASRV N/A
- ITRM 2018
- Fundamental
- Price
- ASRV $2.73
- ITRM $1.77
- Analyst Decision
- ASRV
- ITRM Strong Buy
- Analyst Count
- ASRV 0
- ITRM 1
- Target Price
- ASRV N/A
- ITRM $5.00
- AVG Volume (30 Days)
- ASRV 10.2K
- ITRM 1.5M
- Earning Date
- ASRV 01-21-2025
- ITRM 11-14-2024
- Dividend Yield
- ASRV 4.40%
- ITRM N/A
- EPS Growth
- ASRV N/A
- ITRM N/A
- EPS
- ASRV N/A
- ITRM N/A
- Revenue
- ASRV $45,540,000.00
- ITRM N/A
- Revenue This Year
- ASRV N/A
- ITRM N/A
- Revenue Next Year
- ASRV N/A
- ITRM N/A
- P/E Ratio
- ASRV N/A
- ITRM N/A
- Revenue Growth
- ASRV N/A
- ITRM N/A
- 52 Week Low
- ASRV $2.20
- ITRM $0.81
- 52 Week High
- ASRV $3.40
- ITRM $3.02
- Technical
- Relative Strength Index (RSI)
- ASRV 42.54
- ITRM 46.56
- Support Level
- ASRV $2.81
- ITRM $1.63
- Resistance Level
- ASRV $2.91
- ITRM $1.95
- Average True Range (ATR)
- ASRV 0.11
- ITRM 0.27
- MACD
- ASRV -0.02
- ITRM -0.10
- Stochastic Oscillator
- ASRV 17.83
- ITRM 10.39
About ASRV AmeriServ Financial Inc.
AmeriServ Financial Inc is a bank holding company. The company and its subsidiaries derive substantially all of their income from banking, bank-related services, and trust-related services. Its operating segment includes community banking; wealth management and investment/parent. The company generates maximum revenue from the community banking segment. The community banking segment includes both retail and commercial banking activities. Retail banking includes the deposit-gathering branch franchise and lending to both individuals and small businesses. Lending activities include residential mortgage loans, direct consumer loans and small business commercial loans. Commercial banking to businesses includes commercial loans, business services, and CRE loans.
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents. The company operates as a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.